24 November 2022
Pharma C Investments PLC
("Pharma C" or the "Company")
Notice of AGM
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on companies that provide ancillary products and services to the medicinal cannabis sectors, announces that further to the announcement of 18 November 2022, the Annual General Meeting will now be held at 11am on Tuesday 20th December at the offices of Hill Dickinson LLP. Notice will be posted to shareholders today and will also be available on the company's website.
The Directors of the Company accept responsibility for the contents of this announcement.
For further information please visit www.pharmacinvestments.com
For additional information please contact:
Pharma C Investments
Gavin Sathianathan, Investment Strategy Director
gavin@pharmacinvestments.com
Novum Securities
(AQSE Corporate Adviser)
Tel: +44 207 399 9400
David Coffman
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
